| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||
Net (loss) income | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Non-cash items included in net (loss) income: | ||||||||||
Depreciation and amortization of property and equipment | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Amortization of route and customer acquisition costs and location contracts acquired | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Amortization of debt issuance costs | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Stock-based compensation | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
(Gain) loss on disposal of property and equipment | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Loss on write-off of route and customer acquisition costs and route and customer acquisition costs payable | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Remeasurement of contingent consideration | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payments on consideration payable | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Accretion of interest on route and customer acquisition costs payable, contingent consideration, and contingent stock consideration | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Prepaid expenses and other current assets | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Income taxes receivable | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Route and customer acquisition costs | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Route and customer acquisition costs payable | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Accounts payable and accrued expenses | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Other assets | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Net (loss) income attributable to ordinary shares | ||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Prepaid expenses | ||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Accrued professional fees, travel and other expenses | ||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Interest on Investments held in Trust Account | ||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Net cash (used in) provided by operating activities | ||||||||||
23,316,000 | 45,565,000 | 40,709,925 | 44,662,900 | 62,449,282 | 44,343,000 | 0 | 0 | 0 | - | - |
Cash flows from investing activities: | ||||||||||
Purchases of property and equipment | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Proceeds from the sale of property and equipment | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Net cash used in operating activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Proceeds deposited into Trust Account | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Net cash used in investing activities | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Cash flows from financing activities: | ||||||||||
Payments on term loan | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Proceeds from delayed draw term loans | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payments on delayed draw term loans | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Net payments on line of credit | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payments for debt issuance costs | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payments on consideration payable | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payments on capital lease obligation | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Payment of underwriters discounts | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Payment of accrued offering costs | ||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Proceeds from sale of Units in initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Proceeds from sale of Private Placement Warrants to Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Proceeds of notes payable from Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Repayment of notes payable from Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Net cash provided by (used in) financing activities | ||||||||||
0 | - | - | - | 36,922,629 | 46,122,000 | 0 | 0 | 0 | - | - |
Net increase in cash | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Supplemental disclosures of cash flow information: | ||||||||||
Interest, net of amount of capitalized | ||||||||||
0 | - | - | - | - | - | - | - | - | - | - |
Supplemental schedules of noncash investing and financing activities: | ||||||||||
Purchases of property and equipment in accounts payable and accrued liabilities | ||||||||||
0 | - | - | - | - | - | - | - | - | - | - |
Acquisition of businesses and assets: | ||||||||||
Net cash provided by (used in) financing activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Net change in cash | ||||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Deferred underwriting compensation | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Accrued offering costs | ||||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 | 0 |